Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA’s PCSC Honors Four Outstanding Security Leaders at Annual Seminar
The Healthcare Distribution Alliance (HDA) Pharmaceutical Cargo Security Coalition (PCSC) today recognized four security leaders at the annual PCSC Educational Seminar in Whippany, N.J. The PCSC Award is presented to supply chain security professionals who have exhibited remarkable standards of honesty and integrity while working tirelessly to protect and serve their communities.
HDA Statement on FDA’s Phased Exemption for Eligible Trading Partners from the DSCSA’s Final Implementation Requirements
HDA released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) issuing of an exemption for eligible trading partners to comply with the final requirements of the Drug Supply Chain Security Act (DSCSA).
HDA Research Foundation Names Apotex and Anda Executives To Lead Board of Directors
The HDA Research Foundation announced Steve Giuli of Apotex Corp. as Chairman of its Board of Directors. Anthony Mihelich of Anda, Inc., was named Vice Chairman.
HDA Convenes Supply Chain Experts and Patient Advocates To Examine Drug Shortages Solutions
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions. The event featured perspectives from Laura Bray, Chief Change Maker and Founder of Angels for Change, and April Giles, Executive Director of the End Drug Shortages Alliance (EDSA). Chip Davis, HDA President and Chief Executive Officer, moderated the discussion, which also touched upon effects of recent hurricanes on the prescription supply and the newly announced Biden Cancer Moonshot pilot program to curb pediatric shortages.
Read three takeaways from the conversation.
Debating the Key Issues Shaping the Future of Healthcare
HDA served as a sponsor and participant in the The Hill's recent "Future of Health Care Summit." The event brought together leading healthcare experts to discuss the most critical issues shaping an evolving healthcare landscape, including advancements in patient access to care, the pursuit of health equity and the importance of resetting the care delivery model across the United States.
The summit featured a conversation between HDA’s Dr. Nicolette Louissaint, Senior Vice President of Policy & Strategic Planning, and Sarah Wells Kocsis, Director of the Milken Institute’s Center for Public Health. This blog contains key takeaways from the summit.